Dermatological Products Market

Global Dermatological Products Market Outlook

The global dermatological products market is estimated at USD 15,500 Million in 2022 and is forecast to reach USD 26,400 Million by 2032, growing at a CAGR of 5.4% during 2022-2032.

Report Attributes	Details
Base Year Value (2021A)	USD 14,900 Million
Estimated Year Value (2022E)	USD 15,500 Million
Projected Year Value (2032F)	USD 26,400 Million
Global Growth Rate (2022-2032)	5.4%
North America Market Share in 2021	~24%
North America Growth Rate (2022-2032)	6.3%
Collective Value Share (US, China, UK) in 2021: Top 3 Countries	~30%
Top 3 Companies Market Share in 2021	~22%
Key Companies Profiled	Ikeda Mohando Co. Ltd. Johnson & Johnson Consumer Ltd. Taisho Pharmaceutical Bayer AG GlaxoSmithKline Plc Merck & Co. Inc. Perrigo Company Plc Emami Ltd. Reckitt Benckiser Group Plc Pierre Fabre SA

The global dermatological products market accounts for ~12% of the global skin care products market in 2022. The global dermatological products market is estimated to have an absolute $ opportunity of USD 10,900 Million during the assessment period of 2022-2032.

The demand for dermatological products to treat skin conditions, prevent certain skin disorders, and even to maintain one’s skin is expected to grow at an exciting growth rate in coming years. Inflammatory skin diseases such as acne, dermatitis, psoriasis etc. are treated with the help of biologic agents or protein-based drugs. Thus, the sales for dermatological products combining prescription products and OTC is expected to increase by 2/5th of current value in recent years.

The market demand for dermatological products is rising amongst women owing to the increasing prevalence of skin diseases like rosacea, acne, skin cancer etc. in women in recent years. Thus, over-the-counter dermatological products are expected to boost the market sales by 1.2X.

2017-2021 Global Dermatological Products Market Outlook in Comparison to 2022-2032 Growth Forecast

Manufacturers in dermatological products market are making use of new and advanced technologies like biomarkers, bioinformatics, molecular targeting and nanotechnology for medicine discovery. In dermatological biologics, treatment of psoriasis is the largest area of development, where more than 10 approved biologics are used to treat moderate to severe psoriasis, propelling market growth.

Moreover, increased cases of psoriasis have been witnessed in children worldwide, therefore, manufacturers are working towards evolving effective biologics for children suffering from psoriasis. Additionally, biosimilars having similar ingredients to biologic medicines, and being cost-effective, are poised to witness augmented production in dermatological products market.

Fact.MR projects the dermatological products market to witness exhibiting growth at 5.4% CAGR during 2022-2032 in comparison to a growth rate of3.2% posted during 2017-2021.

Dermo-Cosmetic Products: Effective Solution for Skin Related Complaints

Use of dermo-cosmetic products by consumers to treat common skin conditions such as acne, eczema, reactive skin and extreme skin sensitivity because of rise in incidences of lifestyle-related skin complaints and skin allergies. This is expected to raise the market demand by 2/5th.

New developments are on rise in dermatological products market where skincare range are introduced without any preservatives and fragrance. Additionally, companies are using limited number of chemical ingredients and offering D.E.F.I packaging i.e. Device for Exclusive Formula Integrity (D.E.F.I) packaging which helps to protect formula from oxidation.

Dermatological products providers are working in tandem with dermatologists to develop skin formulations and are also attaching dermatologists recommended claims, to gain consumer loyalty. Thus, makers are witnessing 2/5th additional demand because of consumer belief of these products being safe and effective as assured by dermatologists.

Escalating Skin Problems amongst Children Driving Market Demand

Escalated prevalence of skin conditions such as diaper dermatitis, skin rashes, atopic dermatitis, warts, acne etc. in children constitute a major health problem amongst them. Approximately 24% of children are affected by atopic dermatitis as compared to just 3-4% of adults, according to the American Academy of Dermatology.

Moreover, diaper rash is the most common problem among babies. Rise in bacteria, fungi and viruses is giving rise to eczema among children. Manufacturers in dermatological products market are offering moisturizers to treat eczema and other over-the-counter medications to treat most of the skin problems in children. This is expected to boost sales of dermatological products by nearly 2.1X during the assessment period of 2022-2032.

Increase in Melanoma Driving Market Demand

Melanoma is the 15th most occurring cancer worldwide, where one person dye every hour from rising melanoma cases, according to the Melanoma International Foundation. Thus, with increase in melanoma cases, demand for creams and sunscreen as dermatological products have increased in recent years. Manufacturers are focusing on developing better sunscreen products, self-tanning lotions, moistures etc. providing better protection against UV radiations and tanning, thereby increasing market demand by nearly 16%.

Advanced Technologies in Dermatological Products

Advanced technologies are gaining admiration in dermatological products. Manufacturers are concentrating on introducing new delivery systems and introducing less invasive devices for customers. Many advanced products analyses skin condition with the aid of sensors, and then recommends skin improvement with the help of skin therapy.

Development in nanomedicines, modification in Nano carriers and use of antioxidants, finds large application in cosmetics industry and skin care products. For instance, nanoparticles are widely used in UV-light absorbing sunscreen and anti-aging products. Thus, development in new technologies in dermatological products market is expected to drive market growth by 1.4X.

Side-Effects Remain Biggest Challenge

Consumers are preferring over-the-counter products because of easy availability and convenience in treating skin problems. However, improper and longer usage than recommended time is bound to create side-effects leading to serious health issues.

Many ingredients found in OTC drugs such as hydroquinone have resulted in inflammation, burning, peeling and skin redness if used for longer duration. Thus, these side-effects of dermatological products are shifting consumer preference towards natural and plant-based alternatives and are likely to impact dermatological products market by 0.8X.

Region-wise Insights

What is the market scenario in North American Dermatological Products Market?

North America dermatological products market is expected to witness significant growth in coming years. North America currently holds 23.7% of overall market share, and growing number of skin diseases across all age groups in United States and Canada are poised to create profitable opportunities for manufactures in the region.

In United States, every year more than 50 million people suffer from acne, and approximately 7.5 million people suffer from psoriasis, according to the American Academy of Dermatology.

Additionally, in Canada cancer cases are escalating at rapid level. This is attributed to UV exposure resulting in growing risks of melanoma, the fastest rising cancer. Therefore, consumers are increasingly adopting premium skin care dermatological products such as facial masks, oils, and serums etc. containing natural ingredients. This is expected to boost market growth by 18.7% during the forecast years of 2022-2032.

How much attractive is the market scenario in Asia-Pacific?

Asia-Pacific dermatological products market is expected to register fastest growth during the assessment years. This is mainly attributed to increased awareness regarding the use of dermatological products. In addition to this, evolving life science industry is poised to drive market growth by 1.5X in developing economies of China, India and Malaysia.

Category-wise Insights

What product type is expected to show more demand in Dermatological Products Market in coming years?

Acne treatment products under product type holds major market share of 28.7%. Escalating cases of acne globally, coupled with innovation in treatment is expected to boost demand for acne treatment products. Better understanding of acne pathology along with enhanced research activities is bound to result in new and safe acne treatment products manufactured by makers. Meanwhile, owing to rise in accidents and surgeries, demand for scar and stretch mark products is likely to provide a gain of 136 BPS in dermatological products market.

Which consumer orientation promises more growth in Dermatological Products Market?

Female dermatological products account for major market share i.e. 37.8% of overall market. Factors such as rise in consciousness among pregnant women on developing stretch marks is boosting market. Acne cases are increasing among women. For instance, according to American Academy of Dermatology, acne affects more than 15% of women in United States. This is likely to boost current demand by 1/4th in coming years, for multiple stretch mark products like oil and cream in the dermatological products market globally.

Competitive Landscape: Top Companies in Dermatological Products Market

The global dermatological products market is highly fragmented and competitive owing to the existence of many domestic and regional players. Various marketing strategies are adopted by key players such as mergers and acquisitions, expansions, collaborations and partnerships.

Also, new product development as a strategic approach is adopted by the leading companies to upscale their market presence among consumers. These strategies have resulted in the incorporation of advanced dermatological products.

Fact.MR has provided detailed information about price points of top manufacturers of dermatological products positioned across regions, sales growth, production capacity, and speculative technological expansion in the recently published report.

For instance: Johnson & Johnson Inc. announced in 2022, that Avicanna Inc., the first cannabinoid company is going to be a part of Johnson & Johnson incubator JLABS, which is readying for pharmaceutical distribution. JLABS, provides a favorable flexible environment for company’s startup nature, pursuing research and launching new technologies to advance medical care.

Global Dermatological Products Market by Category

• By Product Type :

  • Cleansers
  • Acne Treatment Products
  • Skin Moisturizer
  • Sunscreen Products
  • Scar & Stretch Mark Products

• By Form :

  • Ointment/Cream/Gel
  • Stick
  • Wipes
  • Oil
  • Powder

• By Consumer Orientation :

  • Female Dermatological Products
  • Male Dermatological Products
  • Kids Dermatological Products

• By Sales Channel :

  • Online Sales
  • Offline Sales
    • Modern Trade
    • Specialty Stores
    • Mono-Brand Stores/Independent/Franchised Stores
    • Drug Stores

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA